SILVERARC CAPITAL MANAGEMENT, LLC - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is and the CUSIP is 29014R202. A total of 19 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SILVERARC CAPITAL MANAGEMENT, LLC ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$260,101
+23.7%
54,0750.0%0.08%
+21.5%
Q2 2023$210,352
+55.0%
54,0750.0%0.06%
+16.1%
Q1 2023$135,728
+177.5%
54,075
+101.2%
0.06%
+300.0%
Q4 2022$48,91426,8760.01%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AMERICAN FINANCIAL GROUP INC 37,000$670.02%
SILVERARC CAPITAL MANAGEMENT, LLC 26,876$48,9140.01%
MENORA MIVTACHIM HOLDINGS LTD. 52,355$95,2860.00%
Altshuler Shaham Ltd 25,123$45,7240.00%
Harel Insurance Investments & Financial Services Ltd. 29,410$540.00%
WELLS FARGO & COMPANY/MN 1,167$2,1240.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 4$70.00%
Tower Research Capital LLC (TRC) 3,789$70.00%
GEODE CAPITAL MANAGEMENT, LLC 20,196$360.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders